Evan J. Anderson
#158,497
Most Influential Person Now
Researcher
Evan J. Anderson's AcademicInfluence.com Rankings
Evan J. Andersoncomputer-science Degrees
Computer Science
#8910
World Rank
#9366
Historical Rank
Computational Linguistics
#2069
World Rank
#2091
Historical Rank
Machine Learning
#3774
World Rank
#3820
Historical Rank
Artificial Intelligence
#4094
World Rank
#4152
Historical Rank
Download Badge
Computer Science
Evan J. Anderson's Degrees
- PhD Computer Science Stanford University
- Masters Computer Science University of California, Berkeley
- Bachelors Computer Science University of California, Berkeley
Similar Degrees You Can Earn
Why Is Evan J. Anderson Influential?
(Suggest an Edit or Addition)Evan J. Anderson's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- An mRNA Vaccine against SARS-CoV-2 — Preliminary Report (2020) (2366)
- Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 — COVID-NET, 14 States, March 1–30, 2020 (2020) (2045)
- Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults. (2015) (1237)
- Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults (2020) (1020)
- Community-acquired pneumonia requiring hospitalization among U.S. children. (2015) (897)
- Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans (2020) (778)
- Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination (2020) (613)
- Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19 (2021) (505)
- Hospitalization Rates and Characteristics of Children Aged <18 Years Hospitalized with Laboratory-Confirmed COVID-19 — COVID-NET, 14 States, March 1–July 25, 2020 (2020) (392)
- Risk Factors for Intensive Care Unit Admission and In-hospital Mortality among Hospitalized Adults Identified through the U.S. Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET) (2020) (386)
- Durability of mRNA-1273 vaccine–induced antibodies against SARS-CoV-2 variants (2021) (322)
- Durability of mRNA-1273 vaccine–induced antibodies against SARS-CoV-2 variants (2021) (322)
- Rotavirus infection in adults (2004) (321)
- Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase (2021) (278)
- Rapid generation of neutralizing antibody responses in COVID-19 patients (2020) (273)
- Characteristics and Maternal and Birth Outcomes of Hospitalized Pregnant Women with Laboratory-Confirmed COVID-19 — COVID-NET, 13 States, March 1–August 22, 2020 (2020) (259)
- Rapid Generation of Neutralizing Antibody Responses in COVID-19 Patients (2020) (236)
- Evaluation of Rhesus Rotavirus Monovalent and Tetravalent Reassortant Vaccines in US Children (1995) (217)
- Impact of a rapid respiratory panel test on patient outcomes. (2015) (213)
- Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells (2021) (209)
- Hospitalizations Associated with COVID-19 Among Children and Adolescents — COVID-NET, 14 States, March 1, 2020–August 14, 2021 (2021) (199)
- Procalcitonin as a Marker of Etiology in Adults Hospitalized With Community-Acquired Pneumonia (2017) (176)
- Infection- and vaccine-induced antibody binding and neutralization of the B.1.351 SARS-CoV-2 variant (2021) (167)
- Rotavirus vaccines: viral shedding and risk of transmission. (2008) (149)
- Influenza Vaccination Modifies Disease Severity Among Community-dwelling Adults Hospitalized With Influenza (2017) (132)
- Clinical Outcomes of Adolescents and Young Adults in Adult HIV Care (2011) (130)
- Serological responses to an avian influenza A/H7N9 vaccine mixed at the point-of-use with MF59 adjuvant: a randomized clinical trial. (2014) (121)
- Staphylococcus aureus Community-acquired Pneumonia: Prevalence, Clinical Characteristics, and Outcomes (2016) (119)
- Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells (2021) (119)
- Potency Analysis of Mesenchymal Stromal Cells Using a Combinatorial Assay Matrix Approach. (2018) (119)
- Effectiveness of COVID-19 Vaccines in Preventing Hospitalization Among Adults Aged ≥65 Years — COVID-NET, 13 States, February–April 2021 (2021) (108)
- Triplex Real-Time RT-PCR for Severe Acute Respiratory Syndrome Coronavirus 2 (2020) (108)
- Racial and Ethnic Disparities in Rates of COVID-19–Associated Hospitalization, Intensive Care Unit Admission, and In-Hospital Death in the United States From March 2020 to February 2021 (2021) (103)
- Quantitative SARS-CoV-2 Serology in Children With Multisystem Inflammatory Syndrome (MIS-C) (2020) (103)
- Hospitalizations of Children and Adolescents with Laboratory-Confirmed COVID-19 — COVID-NET, 14 States, July 2021–January 2022 (2022) (101)
- Indirect protection of adults from rotavirus by pediatric rotavirus vaccination. (2013) (99)
- mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 Omicron variant (2021) (93)
- COVID-19–Associated Hospitalizations Among Health Care Personnel — COVID-NET, 13 States, March 1–May 31, 2020 (2020) (89)
- Potent High-Affinity Antibodies for Treatment and Prophylaxis of Respiratory Syncytial Virus Derived from B Cells of Infected Patients (2009) (87)
- Risk Factors for COVID-19-associated hospitalization: COVID-19-Associated Hospitalization Surveillance Network and Behavioral Risk Factor Surveillance System (2020) (86)
- Association Between Hospitalization With Community-Acquired Laboratory-Confirmed Influenza Pneumonia and Prior Receipt of Influenza Vaccination. (2015) (83)
- Development of a Rapid Focus Reduction Neutralization Test Assay for Measuring SARS‐CoV‐2 Neutralizing Antibodies (2020) (83)
- Procalcitonin Accurately Identifies Hospitalized Children With Low Risk of Bacterial Community-Acquired Pneumonia (2017) (81)
- High‐risk adenovirus‐infected pediatric allogeneic hematopoietic progenitor cell transplant recipients and preemptive cidofovir therapy (2008) (79)
- Hospitalization of Infants and Children Aged 0–4 Years with Laboratory-Confirmed COVID-19 — COVID-NET, 14 States, March 2020–February 2022 (2022) (76)
- Interim Analysis of Risk Factors for Severe Outcomes among a Cohort of Hospitalized Adults Identified through the U.S. Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET) (2020) (73)
- Predicting Severe Pneumonia Outcomes in Children (2016) (73)
- Hospitalization of Adolescents Aged 12–17 Years with Laboratory-Confirmed COVID-19 — COVID-NET, 14 States, March 1, 2020–April 24, 2021 (2021) (72)
- Respiratory Syncytial Virus Disease in Preterm Infants in the US Born at 32–35 Weeks Gestation Not Receiving Immunoprophylaxis (2014) (66)
- Effectiveness of Palivizumab in High-risk Infants and Children (2017) (65)
- Etiology and Impact of Coinfections in Children Hospitalized With Community-Acquired Pneumonia (2017) (64)
- Does Influenza Vaccination Modify Influenza Severity? Data on Older Adults Hospitalized With Influenza During the 2012-2013 Season in the United States. (2015) (61)
- Hospitalizations of Children Aged 5–11 Years with Laboratory-Confirmed COVID-19 — COVID-NET, 14 States, March 2020–February 2022 (2022) (60)
- Social determinants of influenza hospitalization in the United States (2016) (59)
- Influence of Antibiotics on the Detection of Bacteria by Culture-Based and Culture-Independent Diagnostic Tests in Patients Hospitalized With Community-Acquired Pneumonia (2017) (59)
- Warp Speed for Coronavirus Disease 2019 (COVID-19) Vaccines: Why Are Children Stuck in Neutral? (2020) (59)
- COVID-19 vaccine development: a pediatric perspective (2020) (57)
- Rotavirus in adults requiring hospitalization. (2007) (57)
- SENTINEL1: An Observational Study of Respiratory Syncytial Virus Hospitalizations among U.S. Infants Born at 29 to 35 Weeks' Gestational Age Not Receiving Immunoprophylaxis (2016) (55)
- Influenza-Related Hospitalizations and Poverty Levels - United States, 2010-2012. (2016) (53)
- Altered amino acid profile in patients with SARS-CoV-2 infection (2021) (52)
- A Respiratory Syncytial Virus (RSV) Anti-G Protein F(ab′)2 Monoclonal Antibody Suppresses Mucous Production and Breathing Effort in RSV rA2-line19F-Infected BALB/c Mice (2013) (50)
- The Future of Flu: A Review of the Human Challenge Model and Systems Biology for Advancement of Influenza Vaccinology (2019) (47)
- Estimated Burden of Community-Onset Respiratory Syncytial Virus–Associated Hospitalizations Among Children Aged <2 Years in the United States, 2014–15 (2019) (47)
- Impact of Rotavirus Vaccination on Hospital-Acquired Rotavirus Gastroenteritis in Children (2011) (47)
- Severity of Disease Among Adults Hospitalized with Laboratory-Confirmed COVID-19 Before and During the Period of SARS-CoV-2 B.1.617.2 (Delta) Predominance — COVID-NET, 14 States, January–August 2021 (2021) (46)
- Risk Factors for Severe COVID-19 in Children. (2021) (46)
- Molecular Detection and Characterization of Mycoplasma pneumoniae Among Patients Hospitalized With Community-Acquired Pneumonia in the United States (2015) (45)
- COVID-19–Associated Hospitalizations Among Adults During SARS-CoV-2 Delta and Omicron Variant Predominance, by Race/Ethnicity and Vaccination Status — COVID-NET, 14 States, July 2021–January 2022 (2022) (45)
- Reduced binding and neutralization of infection- and vaccine-induced antibodies to the B.1.351 (South African) SARS-CoV-2 variant (2021) (44)
- Pneumococcal Community-Acquired Pneumonia Detected by Serotype-Specific Urinary Antigen Detection Assays (2018) (43)
- The Future of Respiratory Syncytial Virus Disease Prevention and Treatment (2021) (42)
- Child passenger safety laws in the United States, 1978-2010: policy diffusion in the absence of strong federal intervention. (2014) (39)
- Neonatal and Pediatric Candidemia: Results From Population-Based Active Laboratory Surveillance in Four US Locations, 2009–2015 (2018) (39)
- Laboratory-Confirmed COVID-19–Associated Hospitalizations Among Adults During SARS-CoV-2 Omicron BA.2 Variant Predominance — COVID-19–Associated Hospitalization Surveillance Network, 14 States, June 20, 2021–May 31, 2022 (2022) (39)
- Protecting the Community Through Child Vaccination (2018) (38)
- Age-Related Differences in Hospitalization Rates, Clinical Presentation, and Outcomes Among Older Adults Hospitalized With Influenza-U.S. Influenza Hospitalization Surveillance Network (FluSurv-NET). (2019) (38)
- Procalcitonin as an Early Marker of the Need for Invasive Respiratory or Vasopressor Support in Adults With Community-Acquired Pneumonia. (2016) (37)
- Benefit of Early Initiation of Influenza Antiviral Treatment to Pregnant Women Hospitalized With Laboratory-Confirmed Influenza. (2016) (37)
- Outcomes of immunocompromised adults hospitalized with laboratory-confirmed influenza in the United States, 2011-2015. (2019) (37)
- Clinical Trends Among U.S. Adults Hospitalized With COVID-19, March to December 2020 (2021) (35)
- Evaluation of mRNA-1273 Covid-19 Vaccine in Children 6 to 11 Years of Age (2022) (35)
- Serology Enhances Molecular Diagnosis of Respiratory Virus Infections Other than Influenza in Children and Adults Hospitalized with Community-Acquired Pneumonia (2016) (35)
- Durability of mRNA-1273-induced antibodies against SARS-CoV-2 variants (2021) (35)
- Immune dysfunctionality of replicative senescent mesenchymal stromal cells is corrected by IFNγ priming. (2017) (35)
- Acute Cardiovascular Events Associated With Influenza in Hospitalized Adults (2020) (35)
- Prevention and treatment of viral diarrhea in pediatrics (2010) (34)
- Community-Acquired Pneumonia Hospitalization among Children with Neurologic Disorders (2016) (34)
- Prevalence and Characteristics of Human Metapneumovirus Infection Among Hospitalized Children at High Risk for Severe Lower Respiratory Tract Infection. (2012) (33)
- Prevalence, Risk Factors, and Outcomes of Bacteremic Pneumonia in Children (2019) (33)
- Burden of Severe Respiratory Syncytial Virus Disease Among 33–35 Weeks’ Gestational Age Infants Born During Multiple Respiratory Syncytial Virus Seasons (2017) (32)
- Pediatric Dental Clinic–Associated Outbreak of Mycobacterium abscessus Infection (2016) (32)
- Original ResearchCommunity-Acquired Pneumonia Visualized on CT Scans but Not Chest Radiographs: Pathogens, Severity, and Clinical OutcomesPneumonia Seen on CT Only (2017) (31)
- Obesity not associated with severity among hospitalized adults with seasonal influenza virus infection (2015) (31)
- Distinguishing Multisystem Inflammatory Syndrome in Children From COVID-19, Kawasaki Disease and Toxic Shock Syndrome (2022) (31)
- Risk scoring tool to predict respiratory syncytial virus hospitalisation in premature infants (2018) (30)
- SARS-CoV-2 immune repertoire in MIS-C and pediatric COVID-19 (2021) (29)
- A multicenter retrospective study of childhood brucellosis in Chicago, Illinois from 1986 to 2008. (2011) (29)
- Increased Antiviral Treatment Among Hospitalized Children and Adults With Laboratory-Confirmed Influenza, 2010–2015 (2017) (28)
- Respiratory and Nonrespiratory Diagnoses Associated With Influenza in Hospitalized Adults (2020) (28)
- In‐Hospital Deaths Among Adults With Community‐Acquired Pneumonia (2018) (27)
- Pneumococcal and Legionella Urinary Antigen Tests in Community-acquired Pneumonia: Prospective Evaluation of Indications for Testing. (2018) (26)
- COVID-19-Associated Hospitalizations Among Vaccinated and Unvaccinated Adults 18 Years or Older in 13 US States, January 2021 to April 2022 (2022) (26)
- Identification of Adenoviruses in Specimens from High-Risk Pediatric Stem Cell Transplant Recipients and Controls (2007) (25)
- Rhinovirus Viremia in Patients Hospitalized With Community-Acquired Pneumonia (2017) (25)
- Pharmacodynamic Target Attainment for Various Ceftazidime Dosing Schemes in High-Flux Hemodialysis (2013) (25)
- SENTINEL1: Two-Season Study of Respiratory Syncytial Virus Hospitalizations among U.S. Infants Born at 29 to 35 Weeks' Gestational Age Not Receiving Immunoprophylaxis (2019) (24)
- Rates of Influenza-Associated Hospitalization, Intensive Care Unit Admission, and In-Hospital Death by Race and Ethnicity in the United States From 2009 to 2019 (2021) (24)
- A series of skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus in HIV-infected patients. (2006) (24)
- Effectiveness of &bgr;-Lactam Monotherapy vs Macrolide Combination Therapy for Children Hospitalized With Pneumonia (2017) (24)
- Community-Acquired Pneumonia Visualized on CT Scans but Not Chest Radiographs (2017) (24)
- Echocardiography in Pediatric Infective Endocarditis (2011) (24)
- Statin Use and Hospital Length of Stay Among Adults Hospitalized With Community-acquired Pneumonia. (2016) (23)
- The Effect of Anticoagulants, Temperature, and Time on the Human Plasma Metabolome and Lipidome from Healthy Donors as Determined by Liquid Chromatography-Mass Spectrometry (2019) (23)
- The development and kinetics of functional antibody-dependent cell-mediated cytotoxicity (ADCC) to SARS-CoV-2 spike protein (2021) (21)
- Effects of Chronologic Age and Young Child Exposure on Respiratory Syncytial Virus Disease among US Preterm Infants Born at 32 to 35 Weeks Gestation (2016) (20)
- Systems Vaccinology for a Live Attenuated Tularemia Vaccine Reveals Unique Transcriptional Signatures That Predict Humoral and Cellular Immune Responses (2019) (19)
- The Importance of Advancing SARS-CoV-2 Vaccines in Children (2020) (19)
- Factors Associated with Severe Outcomes Among Immunocompromised Adults Hospitalized for COVID-19 — COVID-NET, 10 States, March 2020–February 2022 (2022) (19)
- Identification of Bacterial and Viral Codetections With Mycoplasma pneumoniae Using the TaqMan Array Card in Patients Hospitalized With Community-Acquired Pneumonia (2016) (19)
- Relationship Between Body Mass Index and Outcomes Among Hospitalized Patients With Community-Acquired Pneumonia (2017) (19)
- Multicenter clinical performance evaluation of BD Veritor™ system for rapid detection of respiratory syncytial virus. (2014) (18)
- The impact of infection control upon hospital-acquired influenza and respiratory syncytial virus (2013) (18)
- Implications of SARS-CoV-2 Viral Load in Children: Getting Back to School and Normal. (2021) (17)
- A rational approach to the management of ventricular shunt infections. (2005) (16)
- Phase Ib Trial To Evaluate the Safety and Pharmacokinetics of Multiple Ascending Doses of Filociclovir (MBX-400, Cyclopropavir) in Healthy Volunteers (2019) (16)
- Mupirocin for Staphylococcus aureus Decolonization of Infants in Neonatal Intensive Care Units (2018) (15)
- Molecular epidemiology of norovirus in children and the elderly in Atlanta, Georgia, United States (2016) (15)
- Low Admission Plasma Gelsolin Concentrations Identify Community-acquired Pneumonia Patients at High Risk for Severe Outcomes. (2018) (15)
- Clinical Features and Outcomes of Immunocompromised Children Hospitalized With Laboratory-Confirmed Influenza in the United States, 2011-2015. (2018) (15)
- Original antigenic sin responses to Betacoronavirus spike proteins are observed in a mouse model, but are not apparent in children following SARS-CoV-2 infection (2021) (15)
- Clinical characteristics and genotypes of rotavirus in adults. (2015) (14)
- Blastomycosis in Children: A Study of 14 Cases. (2013) (14)
- Intent to Vaccinate SARS-CoV-2 Infected Children in US Households: A Survey (2021) (14)
- The Importance of Advancing Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines in Children. (2021) (13)
- Safety and immunogenicity of a modified vaccinia Ankara vaccine using three immunization schedules and two modes of delivery: A randomized clinical non-inferiority trial. (2017) (13)
- Antibiotic Prescribing for Adults Hospitalized in the Etiology of Pneumonia in the Community Study (2017) (13)
- Transcriptomic and Metabolic Responses to a Live-Attenuated Francisella tularensis Vaccine (2020) (13)
- Clinical Features of Human Metapneumovirus-Associated Community-Acquired Pneumonia Hospitalizations. (2020) (13)
- SARS-CoV-2 Variant Vaccine Boosters Trial: Preliminary Analyses (2022) (13)
- Insurance Status and the Risk of Severe Respiratory Syncytial Virus Disease in United States Preterm Infants Born at 32–35 Weeks Gestational Age (2016) (12)
- Secretory phospholipase A2 in SARS-CoV-2 infection and multisystem inflammatory syndrome in children (MIS-C) (2021) (12)
- Pre-existing SARS-CoV-2 immunity influences potency, breadth, and durability of the humoral response to SARS-CoV-2 vaccination (2022) (12)
- Characteristics of Adults Aged 18–49 Years Without Underlying Conditions Hospitalized With Laboratory-Confirmed Coronavirus Disease 2019 in the United States: COVID-NET—March–August 2020 (2020) (12)
- Distinguishing immune activation and inflammatory signatures of multisystem inflammatory syndrome in children (MIS-C) versus hemophagocytic lymphohistiocytosis (HLH) (2022) (12)
- Viral diagnostics and antiviral therapy in hematopoietic stem cell transplantation. (2008) (11)
- Polymicrobial Ventriculitis Involving Pseudomonas fulva (2014) (11)
- Comparison of influenza and COVID-19–associated hospitalizations among children < 18 years old in the United States—FluSurv-NET (October–April 2017–2021) and COVID-NET (October 2020–September 2021) (2022) (11)
- Limited induction of SARS-CoV-2–specific T cell responses in children with multisystem inflammatory syndrome compared with COVID-19 (2022) (10)
- In-Hospital Pneumococcal Polysaccharide Vaccination Is Associated With Detection of Pneumococcal Vaccine Serotypes in Adults Hospitalized for Community-Acquired Pneumonia (2015) (10)
- Evaluation of mRNA-1273 Vaccine in Children 6 Months to 5 Years of Age (2022) (10)
- Parainfluenza Virus Types 1-3 Infections Among Children and Adults Hospitalized with Community-Acquired Pneumonia. (2020) (10)
- Acute Cardiovascular Events Associated With Influenza in Hospitalized Adults A Cross-sectional Study (2020) (9)
- Loss of Pfizer (BNT162b2) Vaccine-Induced Antibody Responses against the SARS-CoV-2 Omicron Variant in Adolescents and Adults (2022) (9)
- Census tract socioeconomic indicators and COVID-19-associated hospitalization rates—COVID-NET surveillance areas in 14 states, March 1–April 30, 2020 (2021) (9)
- Clinical Epidemiology and Outcomes of Pediatric Musculoskeletal Infections. (2021) (9)
- Optimism and caution for an inactivated COVID-19 vaccine (2021) (8)
- Time to begin a new chapter and expand rotavirus immunization. (2014) (8)
- Rotavirus vaccination: short-term indirect herd protection, long-term uncertainty (2013) (8)
- Influenza Antiviral Treatment and Length of Stay (2021) (8)
- A phase 1, randomized, controlled dose-escalation study of EP-1300 polyepitope DNA vaccine against Plasmodium falciparum malaria administered via electroporation. (2016) (8)
- Cerebrospinal fluid cytokine, chemokine, and SARS-CoV-2 antibody profiles in children with neuropsychiatric symptoms associated with COVID-19 (2021) (8)
- Prevalence of Staphylococcus aureus and Use of Antistaphylococcal Therapy in Children Hospitalized with Pneumonia (2018) (8)
- Exclusive Breastfeeding, the Early-life Microbiome and Immune Response, and Common Childhood Respiratory Illnesses. (2022) (8)
- Rotavirus and Norovirus in Pediatric Healthcare-Associated Gastroenteritis (2016) (7)
- Risk Factors for Severe COVID-19 in Children. (2021) (7)
- Association between mixed rotavirus vaccination types of infants and rotavirus acute gastroenteritis. (2015) (7)
- COVID-19 Investigational Treatments in Use Among Hospitalized Patients Identified Through the US Coronavirus Disease 2019–Associated Hospitalization Surveillance Network, March 1–June 30, 2020 (2020) (7)
- Serology in Children with Multisystem Inflammatory Syndrome (MIS-C) associated with COVID-19 (2020) (7)
- Trends in rotavirus from 2001 to 2015 in two paediatric hospitals in Atlanta, Georgia (2018) (7)
- Importance of On-time RotaTeq Vaccination and Long-term Active Surveillance (2008) (7)
- Serologic and Cytokine Signatures in Children With Multisystem Inflammatory Syndrome and Coronavirus Disease 2019 (2022) (7)
- Metabolic Reprogramming of Nasal Airway Epithelial Cells Following Infant Respiratory Syncytial Virus Infection (2021) (6)
- Indirect protection and indirect measures of protection from rotavirus in adults. (2012) (6)
- Evaluation of Cellular and Serological Responses to Acute SARS-CoV-2 Infection Demonstrates the Functional Importance of the Receptor-Binding Domain (2021) (6)
- Osteopontin as a biomarker for COVID-19 severity and multisystem inflammatory syndrome in children: A pilot study. (2021) (6)
- 2498. Association of Increasing Age With Hospitalization Rates, Clinical Presentation, and Outcomes Among Older Adults Hospitalized With Influenza—US Influenza Hospitalization Surveillance Network (FluSurv-NET) (2018) (6)
- Alterations in the Human Plasma Lipidome in Response to Tularemia Vaccination (2020) (6)
- COVID-19–Associated Hospitalizations Among U.S. Infants Aged <6 Months — COVID-NET, 13 States, June 2021–August 2022 (2022) (6)
- SENTINEL 1: An Observational Study of Respiratory Syncytial Virus Hospitalizations Among United States Infants Born at 29–35 Weeks' Gestational Age Not Receiving Immunoprophylaxis (2015) (5)
- Vaccine Attitudes and COVID-19 Vaccine Intention Among Parents of Children With Kidney Disease or Primary Hypertension (2022) (5)
- Development and optimization of a Zika virus antibody-dependent cell-mediated cytotoxicity (ADCC) assay. (2020) (5)
- Relationship between neighborhood census-tract level socioeconomic status and respiratory syncytial virus-associated hospitalizations in U.S. adults, 2015–2017 (2021) (5)
- Pharmacokinetics and safety of intravenous oseltamivir in infants and children in open-label studies. (2015) (4)
- Acute pancreatitis associated with dolutegravir and lamivudine/abacavir administration. (2015) (4)
- Epidemiology, Clinical Characteristics, and Outcomes of Influenza-Associated Hospitalizations in U.S. Children Over 9 Seasons Following the 2009 H1N1 Pandemic. (2022) (4)
- Rates of Severe Influenza-Associated Outcomes Among Older Adults Living With Diabetes-Influenza Hospitalization Surveillance Network (FluSurv-NET), 2012-2017. (2022) (4)
- Epidural Abscess in Lemierre׳s Syndrome. (2017) (4)
- Spatial and temporal clustering of patients hospitalized with laboratory-confirmed influenza in the United States. (2020) (4)
- A Retrospective Test-Negative Case-Control Study to Evaluate Influenza Vaccine Effectiveness in Preventing Hospitalizations in Children. (2021) (4)
- Hospital-acquired influenza in the United States, FluSurv-NET, 2011–2012 through 2018–2019 (2021) (4)
- Immune responses and therapeutic challenges in paediatric patients with new‐onset acute myeloid leukaemia and concomitant COVID‐19 (2021) (4)
- Oseltamivir Use Among Children and Adults Hospitalized With Community-Acquired Pneumonia (2016) (4)
- Upper Respiratory Tract Bacterial-Immune Interactions during Respiratory Syncytial Virus Infection in Infancy. (2021) (3)
- Vital Signs: Influenza Hospitalizations and Vaccination Coverage by Race and Ethnicity—United States, 2009–10 Through 2021–22 Influenza Seasons (2022) (3)
- Hospital-Acquired Influenza Among Hospitalized Patients, 2011–2015 (2016) (3)
- Influenza vaccine effectiveness and disease burden in children and adolescents with sickle cell disease: 2012‐2017 (2020) (3)
- Duration of Cellular and Humoral Responses after Quadrivalent Human Papillomavirus Vaccination in Healthy Female Adults with or without Prior Type 16 and/or 18 Exposure (2020) (3)
- Functional Antibody Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Variants in Children With Coronavirus Disease 2019, Multisystem Inflammatory Syndrome in Children, and After Two Doses of BNT162b2 Vaccination (2022) (3)
- Proteomic Analysis of Human Immune Responses to Live-Attenuated Tularemia Vaccine (2020) (3)
- Rates of severe influenza-associated outcomes among older adults living with diabetes — FluSurv-NET, 2012–2017 (2022) (3)
- 163 – Campylobacter jejuni and Campylobacter coli (2018) (3)
- Hospitalization Is an Underutilized Opportunity to Vaccinate for Influenza. (2019) (3)
- Effect of Infant RSV Infection on Memory T Cell Responses at Age 2-3 Years (2022) (3)
- Functional antibody responses to SARS-CoV-2 variants in children with COVID-19, MIS-C, and after two doses of BNT162b2 vaccination. (2022) (3)
- Sirolimus‐associated pericardial effusion with cardiac tamponade and interstitial pneumonitis in a hematopoietic stem cell transplant recipient (2019) (3)
- Impact of Vaccination on Nosocomial Transmission of Rotavirus (2009) (3)
- Use of Multiple Imputation to Estimate the Proportion of Respiratory Virus Detections Among Patients Hospitalized With Community-Acquired Pneumonia (2018) (3)
- Functional antibody responses to SARS-CoV-2 variants in children with COVID-19, MIS-C, and after two doses of BNT162b2 vaccination. (2022) (3)
- Rates of respiratory syncytial virus (RSV)-associated hospitalization among adults with congestive heart failure—United States, 2015–2017 (2022) (3)
- Causes of In-hospital and Post discharge Mortality Among Patients Hospitalized with Laboratory-Confirmed Influenza, Influenza Hospitalization Surveillance Network, 2014–2015 (2017) (3)
- Functional Antibody Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Variants in Children With Coronavirus Disease 2019, Multisystem Inflammatory Syndrome in Children, and After Two Doses of BNT162b2 Vaccination (2022) (3)
- Intussusception risk of rotavirus vaccination. (2011) (2)
- Safety and Immunogenicity of a Third Dose of SARS-CoV-2 mRNA Vaccine – An Interim Analysis (2022) (2)
- Burden of respiratory syncytial virus hospitalisation among infants born at 32–35 weeks' gestational age in the Northern Hemisphere: pooled analysis of seven studies (2020) (2)
- Correction: Effects of Chronologic Age and Young Child Exposure on Respiratory Syncytial Virus Disease among US Preterm Infants Born at 32 to 35 Weeks Gestation (2016) (2)
- Gram-Positive Diplococci in a Cerebrospinal Fluid Gram Stain (2016) (2)
- Plasmablast, Memory B Cell, CD4+ T Cell, and Circulating Follicular Helper T Cell Responses to a Non-Replicating Modified Vaccinia Ankara Vaccine (2020) (2)
- Safety and immunogenicity of unadjuvanted subvirion monovalent inactivated influenza H3N2 variant (H3N2v) vaccine in children and adolescents. (2019) (2)
- Fever, Progressive Nonproductive Cough, and Headache (2005) (2)
- Serological response to influenza vaccination among adults hospitalized with community‐acquired pneumonia (2018) (2)
- Missed Opportunities for Rotavirus Vaccination (2019) (2)
- Rotavirus G9 severity data revisited. (2007) (2)
- Intensive care unit admission rates for respiratory syncytial virus infection as a function of age in preterm infants born at 32-35-week gestation and not receiving immunoprophylaxis. (2015) (2)
- hospitalized with influenza during the 2012−13 season in the United States (2015) (2)
- Persistent fevers, weight loss, and abdominal pain (2006) (2)
- Severe pneumonia in children: Causes, diagnosis, and treatment (2008) (2)
- 354. Evidence of Aspergillosis Among Patients With Influenza-Associated Hospitalizations—United States, 2005–2017 (2018) (2)
- Original antigenic sin responses to heterologous Betacoronavirus spike proteins are observed in mice following intramuscular administration, but are not apparent in children following SARS-CoV-2 infection (2021) (2)
- 780Clinical Characteristics And Outcomes among Children with Neurological Disorders Hospitalized with Community-acquired Pneumonia (CAP) in the Etiology of Pneumonia in the Community (EPIC) Study (2014) (1)
- Neighborhood-Level Poverty, Poverty-Associated Factors, and Severe Outcomes among Adults Hospitalized with Influenza—United States, 2012–2015 (2017) (1)
- 1717. Relationship between Neighborhood Census-tract Level Poverty and Respiratory Syncytial Virus (RSV)-associated Hospitalizations in U.S. adults, 2015-2017 (2020) (1)
- 746. Characteristics of Respiratory Syncytial Virus (RSV) Infection Among Hospitalized Adults, United States, 2014–2017 (2018) (1)
- 2209. RSV-associated Hospitalizations in Adults Aged ≥18 Years and the Impact of the COVID-19 Pandemic in the United States, October 2018 – February 2022 (2022) (1)
- Seven years of chronic hepatitis C virus infection in an HIV-infected man without detectable antibodies (2015) (1)
- Functional antibody-dependent cell mediated cytotoxicity (ADCC) responses to vaccine and circulating influenza strains following vaccination. (2022) (1)
- Respiratory Infections (2014) (1)
- Respiratory syncytial virus infection during infancy and asthma during childhood in the USA (INSPIRE): a population-based, prospective birth cohort study (2023) (1)
- Immunogenicity and safety of different dose schedules and antigen doses of an MF59-adjuvanted H7N9 vaccine in healthy adults aged 65 years and older. (2021) (1)
- Effect of Concomitant Antibiotic and Vaccine Administration on Serologic Responses to Rotavirus Vaccine. (2019) (1)
- Functional antibody-dependent cell mediated cytotoxicity (ADCC) responses to vaccine and circulating influenza strains following vaccination. (2022) (1)
- Impact of pregnancy on observed sex disparities among adults hospitalized with laboratory‐confirmed influenza, FluSurv‐NET, 2010‐2012 (2017) (1)
- Viral genetic determinants of prolonged respiratory syncytial virus infection among infants in a healthy term birth cohort. (2022) (1)
- Intussusception risk increased after rotavirus vaccination but outweighed by benefits (2014) (1)
- Estimation of childhood nephrotic syndrome incidence: data from the atlanta metropolitan statistical area and meta-analysis of worldwide cases (2021) (1)
- Respiratory syncytial virus hospitalizations in US preterm infants after the 2014 change in immunoprophylaxis guidance by the American Academy of Pediatrics (2020) (1)
- JAMA Peer Reviewers in 2018. (2019) (1)
- Association Between Rotavirus Vaccination and Antibiotic Prescribing Among Commercially Insured US Children, 2007–2018 (2022) (1)
- JAMA Peer Reviewers in 2020. (2021) (1)
- JAMA Peer Reviewers in 2019. (2020) (1)
- 1504. Risk of Influenza-Associated Hospitalization Among Older Adults Living with Diabetes — United States, 2012–2017 (2020) (1)
- JAMA Peer Reviewers in 2021. (2022) (1)
- Nucleic acid biomarkers of immune response and cell and tissue damage in children with COVID-19 and MIS-C (2022) (1)
- Evaluation of a SARS-CoV-2 Capture IgM Antibody Assay in Convalescent Sera (2021) (1)
- A Retrospective Case-Controlled Study of Rotavirus Vaccine Effectiveness Using Rapid Antigen Testing (2015) (1)
- Codetections of Other Respiratory Viruses Among Children Hospitalized With COVID-19. (2023) (1)
- Update From the September 2022 Meeting of the Advisory Committee on Immunization Practices (2022) (1)
- COVID-19 Vaccines Have Moved Out of Neutral, but Still Gearing Up in Children (2021) (1)
- Rotavirus infection in adults Panel 2 (1)
- Sensitive and Prolonged Detection of Dengue Virus RNA in Whole Blood. (2021) (1)
- The glory of guidelines and the twilight of reality: controversies and challenges in the prevention and treatment of HIV in children (2012) (1)
- 2494. Influenza B Hospitalizations Are Associated With Mortality in Children, FluSurv-NET, 2011–2017 (2018) (1)
- Acute Cardiac Events During COVID-19-Associated Hospitalizations (2023) (1)
- Safety and immunogenicity of high doses of quadrivalent influenza vaccine in children 6 months through <18 years of age: A randomized controlled phase II dose-finding trial. (2021) (1)
- Baseline Levels of Influenza-Specific B Cells and T Cell Responses Modulate Human Immune Responses to Swine Variant Influenza A/H3N2 Vaccine (2020) (1)
- Viral PCR testing associated with decreased healthcare resource utilization. (2016) (1)
- Diminished monocyte response in severe COVID-19 patients. (2021) (0)
- 1407. Cytomegalovirus (CMV) infection in the first year of life in a cohort of infants in rural Guatemala (2020) (0)
- 2280. Antibiotic Exposure Does Not Impact Serological Responses to Rotavirus Vaccination (2018) (0)
- 1116Rotavirus in Adults in the Post-Rotavirus Vaccine Era (2014) (0)
- Effectiveness of Antiviral Treatment Among Children Hospitalized With Laboratory-Confirmed Influenza (2015) (0)
- 1712. Epidemiology, Clinical Characteristics, and Outcomes of Influenza-Associated Hospitalizations in Children in the post-2009 Pandemic Era (2020) (0)
- A New Virus-tolerant Southernpea (1998) (0)
- Rotavirus in Adults: A Survey of Hospitalized Adults with Acute Gastroenteritis (2006) (0)
- Longitudinal Neutralizing and Functional Antibody Responses to SARS-CoV-2 Variants following mRNA COVID-19 Vaccination (2023) (0)
- 1934. Association between Receipt of COVID-19, Influenza, and Pneumococcal Vaccination (2022) (0)
- 2212. Burden of Community-Acquired Pneumonia Attributable to Co-morbid Conditions in Adults (2019) (0)
- Abstract PO-012: Clinical features and antibody response of two pediatric patients presenting with new-onset acute myeloid leukemia and concomitant severe COVID-19 (2020) (0)
- Pharmacodynamic Target Attainment for Various Ceftazidime Dosing Schemes in High- 1 (2013) (0)
- 2801. Post-Natal Zika Virus Infection and Impact on Neurodevelopment Among a Cohort of Children in Rural Guatemala (2019) (0)
- 160. Safety and Immunogenicity of Escalating Dose Formulations of High-dose Quadrivalent Influenza Vaccine in Children 6 Months Through < 18 Years of Age (2020) (0)
- 94. Pneumonia Severity Scores Poorly Predict Severe Outcomes Among Adults Hospitalized with Influenza (2019) (0)
- Sinusitis, periorbital edema, and ocular proptosis (2005) (0)
- 3258 The Relationship Between the Severity of Influenza-Related Illness and Timing of Seasonal Influenza Vaccination in Hospitalized Patients with Influenza (2019) (0)
- Palivizumab Effectiveness in Preventing Respiratory Syncytial Virus-Associated Hospitalization in High-Risk Infants and Children (2015) (0)
- #52: Clinical Features and Management of Pediatric Patients Presenting with New Onset Acute Leukemia and Concomitant COVID-19 (2021) (0)
- 781Rhinovirus in Children Hospitalized with Community Acquired Pneumonia: Insights from the Centers for Disease Control and Prevention (CDC) Etiology of Pneumonia in the Community (EPIC) Study (2014) (0)
- 1908. Social Risk Factors for COVID-19-Related Hospitalizations in Adults (2022) (0)
- Respiratory Syncytial Virus (RSV) Hospitalizations of US Preterm Infants Born at 29–35 Weeks Gestational Age: Proportions by Chronologic Age and Birth Month (2017) (0)
- Robust antibody responses in children after Pfizer vaccination (2022) (0)
- 164 – Other Campylobacter Species (2018) (0)
- 1334. Outcomes Among Influenza and SARS-CoV-2 Infection in Hospitalized Adults Age ≥ 50 Years and with Underlying Chronic Obstructive Pulmonary Disease (COPD) or Congestive Heart Failure (CHF) (2021) (0)
- Challenging Vaccine Consults (2016) (0)
- 1114Variability in Pediatric Rotavirus Disease in the Post-Vaccine Era (2014) (0)
- 1621. Acute Cardiovascular Events Among Adults Hospitalized with Influenza, FluSurv-NET, 2010–2018 (2019) (0)
- Association of Radiology Findings with Etiology of Community Acquired Pneumonia Among Children from the Etiology of Pneumonia in the Community (EPIC) Study. (2023) (0)
- 196 Prevalence, Clinical Characteristics, and Outcomes of Adults Hospitalized With Staphylococcus Aureus Community-Acquired Pneumonia (2015) (0)
- LB17. Age-Related Differences in Influenza Type/Subtype Among Patients Hospitalized with Influenza, FluSurv-NET—2017–2018 (2018) (0)
- LB-2Avian Influenza A/H7N9 Vaccine Mixed with MF59 Adjuvant at the Point-of-Use. A Randomized Clinical Trial of a Pandemic Threat Response (2014) (0)
- 846. Postnatally Acquired Zika Virus (ZIKV) Infection in Infants and Young Children in Guatemala: Serologic and Neurodevelopmental (ND) Evaluation (2019) (0)
- Dose-Response of a Norovirus GII.2 Controlled Human Challenge Model Inoculum. (2022) (0)
- Timely Arterial Blood Gas (ABG) Associated With Better Outcomes Among Hypoxemic Community-Acquired Pneumonia Patients (2012) (0)
- Persistence of Immunogenicity of a Purified Inactivated Zika Virus Vaccine Candidate in Healthy Adults: 2 Years of Follow-Up Compared With Natural Infection. (2022) (0)
- Human rhinovirus viremia in patients hospitalized with community-acquired pneumonia (2016) (0)
- 303. Viral and bacterial infections among adults hospitalized with COVID-19, Coronavirus Disease 2019-Associated Hospitalization Surveillance Network, 14 states, March 2020–February 2022 (2022) (0)
- Missed Opportunities for Rotavirus Vaccination from the 2013 National Immunization Survey (2016) (0)
- Longitudinal Neutralizing and Functional Antibody Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Variants Following Messenger RNA Coronavirus Disease 2019 Vaccination (2023) (0)
- RSV Disease: Current Management and the Future of Treatment and Prevention (2021) (0)
- Predicting Severe Outcomes in Children Hospitalized with Community-Acquired Pneumonia (2015) (0)
- 1714Influenza antiviral agent use among adults hospitalized with community-acquired pneumonia (2014) (0)
- Serologic responses to COVID-19 vaccination in children with history of multisystem inflammatory syndrome (MIS-C) (2022) (0)
- Vaccination Status and Trends in Adult COVID-19-Associated Hospitalizations by Race and Ethnicity, March 2020-August 2022. (2023) (0)
- Drug use and severe outcomes among adults hospitalized with influenza, 2016–2019 (2022) (0)
- Safety and Immunogenicity of Influenza A/H5N8 Virus Vaccine in Healthy Adults: Durability and Cross-reactivity of Antibody Responses. (2023) (0)
- 757. Association between cumulative febrile, respiratory and diarrheal illness in the first year of life and neurodevelopmental and growth outcomes among a cohort of children in rural Guatemala (2020) (0)
- The Historical Understanding of Sanitation and Disease Control in New Jersey (2013) (0)
- 898. Influenza Vaccination Reduces Risk of Severe Outcomes among Adults Hospitalized with Influenza A(H1N1)pdm09, FluSurv-NET, 2013–2018 (2019) (0)
- Identification of Adenoviruses in Specimens from High-Risk Pediatric Stem Cell Transplant Recipients and Controls (cid:1) (2007) (0)
- Influenza Antiviral Use in Patients Hospitalized With Laboratory-Confirmed Influenza in the United States, FluSurv-NET, 2015-2019. (2020) (0)
- Prevalence of SARS-CoV-2 and Influenza Coinfection and Clinical Characteristics Among Children and Adolescents Aged <18 Years Who Were Hospitalized or Died with Influenza — United States, 2021–22 Influenza Season (2022) (0)
- Subgenomic RNA abundance relative to total viral RNA among SARS-CoV-2 variants (2022) (0)
- 1340. The Burden of Influenza and Rhinovirus Among Hospitalized Adults Post the COVID-19 Pandemic (2021) (0)
- Prevalence of Respiratory Viral Pathogen Testing and Co-Detections Among Patients Hospitalized With Influenza, 2012–2015 (2016) (0)
- 1068. Prior SARS-CoV-2 infection and risk of subsequent COVID-19-related hospitalization: a test negative design (2022) (0)
- SENTINEL1: An Ongoing Multicenter Observational Study of Respiratory Syncytial Virus Hospitalizations Among United States Infants Born at 29–35 Weeks' Gestational Age Not Receiving Immunoprophylaxis in 2014–2016 (2016) (0)
- Vaccination With Pneumococcal Polysaccharide Vaccine Is Associated With Detection Of Specific Pneumococcal Serotypes In Adults Hospitalized For Community-Acquired Pneumonia (2015) (0)
- Infants and young children generate more durable antibody responses to SARS-CoV-2 infection than adults (2023) (0)
- Does Influenza Vaccination Modify Influenza Disease Severity? Data on Adults Hospitalized With Influenza During the 2013–14 Season in the United States (2015) (0)
- Fever and confusion (2006) (0)
- 2741. Seasonal Influenza Vaccine Timing in Children and Adults Hospitalized with Influenza in the United States, FluSurv-NET, 2013–2017 (2019) (0)
- Limitations Of LCD-9-Derived Pneumonia Core Measures Cohorts (2011) (0)
- 1537. Influenza-Associated Hospitalization Rates and Proportion of Hospitalizations with Influenza and SARS-CoV-2 Coinfection, FluSurv-NET, October 1, 2021–April 23, 2022 (2022) (0)
- Identi fi cation of Bacterial and Viral Codetections With Mycoplasma pneumoniae Using the TaqMan Array Card in Patients Hospitalized With Community-Acquired Pneumonia (2016) (0)
- SARS-CoV-2 Antigenemia is Associated With Pneumonia in Children But Lacks Sensitivity to Diagnose Acute Infection (2022) (0)
- Subgenomic RNA Abundance Relative to Total Viral RNA Among Severe Acute Respiratory Syndrome Coronavirus 2 Variants (2022) (0)
- Red Blood Cell Distribution Width and Pediatric Community-Acquired Pneumonia Disease Severity. (2022) (0)
- The Vacc-SeqQC project: Benchmarking RNA-Seq for clinical vaccine studies (2022) (0)
- Bacterial and viral infections among adults hospitalized with COVID‐19, COVID‐NET, 14 states, March 2020–April 2022 (2023) (0)
- Multiplatform analyses reveal distinct drivers of systemic pathogenesis in adult versus pediatric severe acute COVID-19 (2023) (0)
- Southern Society for Clinical Investigation 2015 Newly Elected Members. (2015) (0)
- CREATING A UNIVERSAL RISK FACTOR MODEL FOR RESPIRATORY SYNCYTIAL VIRUS (RSV) HOSPITALISATIONS IN 33-35 WEEKS' GESTATIONAL AGE (WGA) INFANTS IN THE NORTHERN HEMISPHERE (2016) (0)
- Addressing Rotavirus Vaccination Missed Opportunities Using the National Immunization Survey (2015) (0)
- LB19. Patterns of Influenza A Hospitalizations by Subtype and Age in the United States, FluSurv-NET, 2018–2019 (2019) (0)
- Clinical Features and Outcomes of Immunocompromised Adults Hospitalized with Laboratory-confirmed Influenza in the USA, 2011–2015 (2017) (0)
- 50 Risk factors for adenoviral disease in pediatric allogeneic stem cell transplant recipients (2006) (0)
- 2797. Rates of Respiratory Syncytial Virus (RSV) Infection among Hospitalized Adults by Congestive Heart Failure Status—United States, 2015–2017 (2019) (0)
- Infant Viral Infections (2018) (0)
- Procalcitonin Concentrations Among Hospitalized Children With Pneumonia: Associations With Etiology and Prognosis (2015) (0)
- RSV disease burden among children under two years of age in the United States (2017) (0)
- An RSV Live-Attenuated Vaccine Candidate Lacking G Protein Mucin Domains Is Attenuated, Immunogenic, and Effective in Preventing RSV in BALB/c Mice (2022) (0)
- 584. Prospective Observational Cohort Study of Serological Responses to COVID-19 Vaccines in Pediatric Kidney Transplant Recipients at a Single Institution (2022) (0)
- 720. Respiratory and Nonrespiratory Complications Among Patients Hospitalized with Influenza, FluSurv-NET, 2016–2017 (2018) (0)
- Rhinovirus Real-Time Reverse-Transcription Polymerase Chain Reaction Assay — (2017) (0)
- 1329. Burden of Respiratory Syncytial Virus (RSV) Infection among Hospitalized Older Adults and Those with Underlying Chronic Obstructive Pulmonary Disease (COPD) or Congestive Heart Failure (CHF) (2021) (0)
- The Residual Vaccine-preventable Burden of Rotavirus Disease (2017) (0)
- Dengue Virus andYellow Fever VirusDetectionUsingReverse Transcription–Insulated Isothermal PCR and Comparison with Real-Time RT-PCR (2020) (0)
- Cat Scratch Disease: 9 Years of Experience at a Pediatric Center (2022) (0)
- 2314. Burden of Respiratory Syncytial Virus (RSV) Infection Among Hospitalized Older Adults and Those with Underlying Chronic Obstructive Pulmonary Disease (COPD) or Congestive Heart Failure (CHF) (2019) (0)
- Factor H autoantibodies contribute to complement dysregulation in multisystem inflammatory syndrome in children (MIS‐C) (2023) (0)
- Your diagnosis, please. A nine-month-old boy with severe interstitial pneumonia. (2006) (0)
- Dengue Virus and Yellow Fever Virus Detection Using Reverse Transcription-Insulated Isothermal PCR and Comparison with Real-Time RT-PCR. (2020) (0)
- Addressing the global burden of paediatric critical COVID-19 and mortality (2022) (0)
- COVID-19 in Children and Safety of SARS-CoV-2 Immunization in Children: Statement of the International Pediatric Association (2021) (0)
- Immunogenicity of the BA.1 and BA.4/BA.5 SARS-CoV-2 Bivalent Boosts: Preliminary Results from the COVAIL Randomized Clinical Trial. (2023) (0)
- 685: SENTINEL1: ICU ADMISSIONS FOR RSV AMONG US INFANTS BORN AT 29–35 WGA NOT RECEIVING IMMUNOPROPHYLAXIS (2016) (0)
- In Appreciation of the Maternal and Child Health Journal’s Peer Reviewers, 2017 (2017) (0)
- Corrigendum: The Vacc-SeqQC project: Benchmarking RNA-Seq for clinical vaccine studies (2023) (0)
- An Oil-in-Water adjuvant significantly increased influenza A/H7N9 split virus Vaccine-Induced circulating follicular helper T (cTFH) cells and antibody responses. (2022) (0)
- Immunogenicity of the BA.1 and BA.4/BA.5 SARS-CoV-2 Bivalent Boosts: Preliminary Results from the COVAIL Randomized Clinical Trial (2023) (0)
- JAMA Peer Reviewers in 2016. (2017) (0)
- JAMA Peer Reviewers in 2018. (2019) (0)
- Longitudinal Neutralizing and Functional Antibody Responses to SARS-CoV-2 Variants following mRNA COVID-19 Vaccination (2023) (0)
- The Challenge of Respiratory Syncytial Virus Human Challenge Studies. (2022) (0)
- Nanoparticle vaccines comprising the respiratory syncytial virus G Protein CX3C chemokine motif induce robust immunity protecting from challenge and disease (P4513) (2013) (0)
- The Impact of Lipopolysaccharide Exposure in Infancy on the Development of Lower Respiratory Tract Infections and Childhood Asthma (2022) (0)
- Effect of Early-life Household Exposure to Lipopolysaccharide on Childhood Asthma Is Modified by 17q12-q21 Genotype (2023) (0)
- Immune Prophylaxis Targeting the Respiratory Syncytial Virus (RSV) G Protein (2023) (0)
- 1334. Outcomes Among Influenza and SARS-CoV-2 Infection in Hospitalized Adults Age ≥ 50 Years and with Underlying Chronic Obstructive Pulmonary Disease (COPD) or Congestive Heart Failure (CHF) (2021) (0)
- Longitudinal Neutralizing and Functional Antibody Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Variants Following Messenger RNA Coronavirus Disease 2019 Vaccination (2023) (0)
- Rates and Risk Factors for RSV Infection Among Term Healthy Infants in a Population-based US Cohort (2023) (0)
- Influence of Sex on Respiratory Syncytial Virus Genotype Infection Frequency and Nasopharyngeal Microbiome (2023) (0)
- The Effect of the Pediatric Upper Respiratory Tract Fungal Microbiome on the Risk of Childhood Asthma (2023) (0)
- Minimally Invasive Sampling Method Identifies Differences in Taxonomic Richness of Nasal Microbiomes in Young Infants Associated with Mode of Delivery (2015) (0)
- An RSV Live-Attenuated Vaccine Candidate Lacking G Protein Mucin Domains Is Attenuated, Immunogenic, and Effective in Preventing RSV in BALB/c Mice (2022) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Evan J. Anderson?
Evan J. Anderson is affiliated with the following schools:
